Dr. Sandra D. Algaze
Claim this profileLos Angeles County-USC Medical Center
Studies Colon Cancer
Studies Colorectal Cancer
3 reported clinical trials
11 drugs studied
Area of expertise
1Colon Cancer
Stage II
Stage III
MSS positive
2Colorectal Cancer
Stage II
Stage III
MSS positive
Affiliated Hospitals
Clinical Trials Sandra D. Algaze is currently running
Chemotherapy Tailored by ctDNA Status
for Colon Cancer
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Recruiting1 award Phase 2 & 3
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting4 awards Phase 318 criteria
More about Sandra D. Algaze
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sandra D. Algaze has experience with
- Fluorouracil
- Leucovorin Calcium
- Oxaliplatin
- Capecitabine
- Leucovorin
- Irinotecan Hydrochloride
Breakdown of trials Sandra D. Algaze has run
Colon Cancer
Colorectal Cancer
Pancreatic Cancer
Adenosquamous Carcinoma
Pancreatic Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandra D. Algaze specialize in?
Sandra D. Algaze focuses on Colon Cancer and Colorectal Cancer. In particular, much of their work with Colon Cancer has involved Stage II patients, or patients who are Stage III.
Is Sandra D. Algaze currently recruiting for clinical trials?
Yes, Sandra D. Algaze is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Sandra D. Algaze has studied deeply?
Yes, Sandra D. Algaze has studied treatments such as Fluorouracil, Leucovorin Calcium, Oxaliplatin.
What is the best way to schedule an appointment with Sandra D. Algaze?
Apply for one of the trials that Sandra D. Algaze is conducting.
What is the office address of Sandra D. Algaze?
The office of Sandra D. Algaze is located at: Los Angeles County-USC Medical Center, Los Angeles, California 90033 United States. This is the address for their practice at the Los Angeles County-USC Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.